Practice of Pharmacy | Midpage20-605Practice of pharmacy without license or temporary permit prohibited.20-606(Formerly Sec. 20-178). Use of the title “pharmacist”.20-607(Formerly Sec. 20-173). Certificate of license, temporary permit or registration to be available for inspection.20-608(Formerly Sec. 20-174). Use of certificate of license, temporary permit or display document by unlicensed person prohibited.20-609(Formerly Sec. 20-184). Pharmacy license to be posted. Business which is not a pharmacy prohibited from using words, displays or symbols indicating it is a pharmacy; exemption.20-609aUse of electronic technology or telepharmacy by hospital. Quality assurance evaluations.20-610(Formerly Sec. 20-166). Dispensing or retail sale of legend drugs, legend devices and certain other drugs by other than pharmacies and hospitals, prohibited.20-611(Formerly Sec. 20-175b). Advertising legend drug prices.20-612Only pharmacy may accept prescription for dispensing.20-612aConfirmation of identification prior to release of controlled substance. Exceptions.20-613(Formerly Sec. 21a-308). Dispensing of drug or legend device pursuant to prescription only; exceptions. Emergency dispensing of drug or device in care-giving, correctional or juvenile training institutions; regulations. Pharmacy technicians. Prescribing practitioner authorized to dispense own prescription, when.20-613aRequests for controlled substance issued on results of answers to electronic questionnaire. Regulations.20-614(Formerly Sec. 20-184b). Prescriptions: Form and content. Offer to consult with pharmacist. Electronic data intermediaries.20-615(Formerly Sec. 20-184c). Prescriptions: Pharmacy to assign serial number and maintain records. Transfer of records to another pharmacy.20-616(Formerly Sec. 20-184d). Prescription refills and transfers. Thirty-day supply of diabetes drugs and devices. Notice to prescribing practitioner. Payment. Referral to federally-qualified health center.20-616aPrescription refills for quantity of drug greater than initial quantity prescribed. Conditions.20-617(Formerly Sec. 20-184e). Prescriptions: Notation of drug quantity, expiration date, generic name and drug manufacturer and MedWatch program information. Label information for generic drug substitutions.20-617aFlavoring agent added to prescription product. Exemptions.20-617bCompliance packaging. Requirements. Regulations.20-618(Formerly Sec. 21a-107). Repackaged drugs not considered misbranded, when.20-619(Formerly Sec. 20-185a). Substitution of generic drugs and biological products. Definitions. Interchangeable biological products. Prescribing practitioners. Pharmacy signs. Dispensing. Records. Regulations.20-619aBiological product prescribing. Prescribing practitioner discussion with patient or representative. Documentation. Patient request to sign for delivery.20-620(Formerly Sec. 20-185g). Pharmacist's duties towards Medicaid recipients: To obtain, record and maintain pertinent patient information about the recipient; to undertake a review of the drugs previously dispensed to the recipient and to offer to discuss the drugs to be dispensed and to counsel the recipient on their correct usage. Exception.20-621(Formerly Sec. 20-185h). Relabeling and dispensing of parenteral medication in hospital and nursing home pharmacies: When allowed.20-621aUse of automated prescription dispensing machine in long-term care pharmacies authorized. Regulations.20-622(Formerly Sec. 20-180a). Licensed practitioners may authorize medication to be dispensed from a hospital emergency room.20-623Sale of nonlegend drugs, nonlegend devices and test strips. Labels, packaging, contents and vending machines. Penalty.20-624Permit to sell nonlegend drugs.20-625Nonlegend veterinary drugs.20-626Confidentiality of pharmacy records.20-627Nonresident pharmacy. Definitions. Certificate of registration. Requirements.20-628Shipping, mailing or delivering legend devices or drugs.20-629Denial, revocation or suspension of nonresident pharmacy certificate of registration. Referral by commission.20-630Advertising.20-631Collaborative drug therapy care plans, management agreements and policies. Scope. Care-giving institutions, devices and qualified pharmacists. Regulations.20-631aCollaborative drug management agreements between pharmacists employed by community pharmacies and one or more physicians or advanced practice registered nurses. Pilot program.20-631bCollaborative drug therapy management agreements entered into prior to October 1, 2010.20-632Regulatory action report re disciplinary action against persons with controlled substance registrations and sanctions against pharmacists or pharmacies.20-633Administration of vaccines and epinephrine cartridge injectors by pharmacists and pharmacy technicians. Disclosures. Training. Recordkeeping. Regulations.20-633aPharmacy rewards program. Plain language summary. Violation.20-633bSterile compounding pharmacies. Sterile compounding by health care institutions. Requirements. Exemption. Regulations.20-633cPrescribing of opioid antagonists by licensed pharmacists. Regulations.20-633dMedical protocol standing order for dispensing of opioid antagonists by licensed pharmacists. Regulations.20-633ePharmacy and institutional pharmacy perpetual inventory of Schedule II controlled substances. Regulations.20-633fOrdering and administration of COVID-19-related, HIV-related and influenza-related tests, and prescribing of HIV-related prophylaxes, by licensed pharmacists. Delegation to advanced pharmacy technicians. Recordkeeping. Confidentiality. Disclosure. Regulations.20-633gOperation of mobile pharmacies by licensed pharmacies. Application. Recordkeeping. Operations. Regulations.20-633hUnscheduled closings by licensed pharmacies. Plan. Disclosures. Prescription transfers. Regulations.20-633iIssuance of prescriptions for epinephrine auto injectors by pharmacists.20-633jAuthorization, refilling and dispensing of legend devices by licensed pharmacists. Notice to prescribing practitioner.20-633kPrescribing of emergency and hormonal contraceptives by licensed pharmacists. Training. Patient screening. Disclosures and notices. Assistance by pharmacy technicians. Recordkeeping. Regulations.20-633lDisclosure of information by licensed pharmacists regarding drugs used for termination of pregnancy. Prohibition concerning automatic reciprocal jurisdiction.20-633mProvision of information concerning personal opioid drug deactivation and disposal system at time of dispensing of an opioid drug.20-634Dispensing group practices and dispensing assistants. Registration. Fees. Exemptions. Prohibitions. Penalties.